State Street Health Care Select Sector SPDR ETF (XLV) Alternatives
State Street Health Care Select Sector SPDR ETF (XLV) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with XLV. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.
Cheapest Alternatives to XLV
XLV charges 0.08% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among XLV alternatives.
| Symbol | Name | Expense Ratio | Inception | |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | 0.08% | Oct 21, 2013 | XLV vs FHLC | |
| Vanguard Health Care ETF | 0.10% | Jan 26, 2004 | XLV vs VHT | |
| Invesco S&P SmallCap Health Care ETF | 0.29% | Apr 7, 2010 | XLV vs PSCH | |
| VanEck Vectors Biotech ETF | 0.35% | Dec 20, 2011 | XLV vs BBH | |
| SPDR S&P Health Care Equipment ETF | 0.35% | Jan 26, 2011 | XLV vs XHE |
Best Risk-Adjusted Alternatives to XLV
Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.
| Symbol | Name | Risk / Return Rank | Inception | |
|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 98 | Dec 16, 2014 | XLV vs BBC | |
| ALPS Medical Breakthroughs ETF | 96 | Dec 31, 2014 | XLV vs SBIO | |
| SPDR S&P Biotech ETF | 93 | Feb 6, 2006 | XLV vs XBI | |
| Tema Oncology ETF | 92 | Aug 14, 2023 | XLV vs CANC | |
| Invesco Nasdaq Biotechnology ETF | 88 | Jun 11, 2021 | XLV vs IBBQ |
Top Performing XLV Alternatives (YTD)
XLV alternatives from the Health & Biotech Equities category, sorted by year-to-date return.
| Symbol | Name | YTD Return | Inception | |
|---|---|---|---|---|
| iShares Genomics Immunology and Healthcare ETF Gen... | 11.45% | Jun 11, 2019 | XLV vs IDNA | |
| Virtus LifeSci Biotech Clinical Trials ETF | 10.01% | Dec 16, 2014 | XLV vs BBC | |
| Tema Oncology ETF | 6.91% | Aug 14, 2023 | XLV vs CANC | |
| SPDR S&P Biotech ETF | 5.43% | Feb 6, 2006 | XLV vs XBI | |
| First Trust Nasdaq Pharmaceuticals ETF | 5.20% | Sep 20, 2016 | XLV vs FTXH |
Lowest Volatility Alternatives to XLV
XLV alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.
| Symbol | Name | Volatility 1Y | Inception | |
|---|---|---|---|---|
| Principal Healthcare Innovators Index ETF | 0.00% | Aug 19, 2016 | XLV vs BTEC | |
| Loncar Cancer Immunotherapy ETF | 0.00% | Oct 13, 2015 | XLV vs CNCR | |
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | XLV vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.59% | Jun 29, 2007 | XLV vs SPAQ | |
| Global X Aging Population ETF | 15.99% | May 9, 2016 | XLV vs AGNG |
Lowest Drawdown Alternatives to XLV
XLV alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.
| Symbol | Name | Max Drawdown 1Y | Inception | |
|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | XLV vs GERM | |
| Horizon Kinetics SPAC Active ETF | -5.30% | Jun 29, 2007 | XLV vs SPAQ | |
| Jpmorgan Healthcare Leaders ETF | -9.68% | Nov 1, 2023 | XLV vs JDOC | |
| VanEck Vectors Pharmaceutical ETF | -10.02% | Dec 20, 2011 | XLV vs PPH | |
| Global X Aging Population ETF | -10.16% | May 9, 2016 | XLV vs AGNG |
Other ETFs from State Street
Most popular State Street ETFs on PortfoliosLab, across asset classes.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | Inception | |
|---|---|---|---|---|---|---|
| State Street SPDR S&P 500 ETF | S&P 500 | 59 | -3.65% | Jan 22, 1993 | XLV vs SPY | |
| SPDR Gold Shares | Gold, Precious Metals | 85 | 10.47% | Nov 18, 2004 | XLV vs GLD | |
| State Street Technology Select Sector SPDR ETF | Technology Equities | 65 | -6.18% | Dec 16, 1998 | XLV vs XLK | |
| State Street SPDR Portfolio S&P 500 Growth ETF | S&P 500, Large Cap Growth Equities | 62 | -6.91% | Sep 25, 2000 | XLV vs SPYG | |
| SPDR Portfolio S&P 500 High Dividend ETF | S&P 500, Dividend | 25 | 5.92% | Oct 21, 2015 | XLV vs SPYD | |
| SPDR Gold MiniShares Trust | Precious Metals, Gold | 86 | 10.46% | Jun 25, 2018 | XLV vs GLDM | |
| State Street Energy Select Sector SPDR ETF | Energy Equities | 58 | 32.76% | Dec 16, 1998 | XLV vs XLE | |
| Utilities Select Sector SPDR Fund | Utilities Equities | 66 | 8.77% | Dec 16, 1998 | XLV vs XLU | |
| SPDR Barclays 1-3 Month T-Bill ETF | Government Bonds | 100 | 0.88% | May 25, 2007 | XLV vs BIL | |
| SPDR Dow Jones Industrial Average ETF | Large Cap Growth Equities | 41 | -2.78% | Jan 14, 1998 | XLV vs DIA |
Often Compared With XLV
What investors most often compare with XLV, based on PortfoliosLab usage data.
Compare XLV with Any Fund or Stock
Compare XLV with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.